MedTrace Logo

the Optimal Surveillance Frequency for Stage II/III Gastric Cancer

NCT05465993 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2311

Last updated 2022-07-20

No results posted yet for this study

Summary

Due to lacking of evidence on surveillance for gastric cancer (GC), this study aimed to determine the optimal postsurgical surveillance strategy for stage II/III GC patients and compare its cost-effectiveness with traditional surveillance strategies.

Conditions

Sponsors & Collaborators

  • Fujian Medical University

    lead OTHER

Principal Investigators

  • Changming Huang, MD · Fujian Medical University Union Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2019-10-01
Completion
2022-07-15

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05465993 on ClinicalTrials.gov